Abstract:The Middle East respiratory syndrome (MERS) is a severe respiratory disease with high fatality rates, caused by the Middle East respiratory syndrome coronavirus (MERS-CoV). The virus initiates infection by binding to the CD26 receptor (also known as dipeptidyl peptidase 4 or DPP4) via its spike protein. Although the receptor-binding domain (RBD) of the viral spike protein and the complex between RBD and the extracellular domain of CD26 have been studied using X-ray crystallography, conflicting studies exist regarding the importance of certain amino acids outside the resolved RBD-CD26 complex interaction interface. To gain atomic-level knowledge of the RBD-CD26 complex, we employed computational simulations to study the complex's dynamic behavior as it evolves from its crystal structure to a conformation stable in solution. Our study revealed previously unidentified interaction regions and interacting amino acids within the complex, determined a novel comprehensive RBD-binding domain of CD26, and by that expanded the current understanding of its structure. Additionally, we examined the impact of a single amino acid substitution, E513A, on the complex's stability. We discovered that this substitution disrupts the complex through an allosteric domino-like mechanism that affects other residues. Since MERS-CoV is a zoonotic virus, we evaluated its potential risk of human infection via animals, and suggest a low likelihood for possible infection by cats or dogs. The molecular structural information gleaned from our insights into the RBD-CD26 complex pre-dissociative states may be proved useful not only from a mechanistic view but also in assessing inter-species transmission and in developing anti-MERS-CoV antiviral therapeutics.

Structure of MERS-CoV Spike Receptor-Binding Domain Complexed with Human Receptor DPP4

Complex Structure of Mers-Cov Spike Glycoprotein with Human Receptor Dpp4

Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry.

Cryo-electron Microscopy Structures of the SARS-CoV Spike Glycoprotein Reveal a Prerequisite Conformational State for Receptor Binding

Cryo-EM Structure of the SARS Coronavirus Spike Glycoprotein in Complex with Its Host Cell Receptor ACE2

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.

Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus As an Essential Target for Vaccine Development.

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design.

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor

Structural Definition of a Neutralization Epitope on the N-terminal Domain of MERS-CoV Spike Glycoprotein

Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein.

Structure-based Discovery of Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor

Middle East Respiratory Syndrome Coronavirus (Mers-Cov) Entry Inhibitors Targeting Spike Protein

Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins

Characterization of the Heptad Repeat Regions, HR1 and HR2, and Design of a Fusion Core Structure Model of the Spike Protein from Severe Acute Respiratory Syndrome (SARS) Coronavirus.

MERS-CoV spike protein: a key target for antivirals

Bioinformatics Analysis on Potential Anti-Viral Targets Against Spike Protein of MERS-CoV

Precise Location of Two Novel Linear Epitopes on the Receptor-Binding Domain Surface of MERS-CoV Spike Protein Recognized by Two Different Monoclonal Antibodies